A new pharmacological agent demonstrates promising results for the prevention of a wide range of heart rhythm disorders, including both cardiac and brain injury-induced arrhythmias. Furthermore, the ...

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have discovered a surprising new role for a pair of compounds—which have the potential to alter circadian rhythm, the ...

Rhythm Pharmaceuticals, Inc. is headquartered in Boston, MA. The company's main asset is a compound is a rare melanocortin-4 receptor called setmelanotide which is injectable. Setmelanotide is more ...

A surprising new role has been found for a pair of compounds that have the potential to alter circadian rhythm, the complex physiological process, present in most living things, that responds to a ...